Modulation of inflammation by vitamin E and C supplementation prior to anterior cruciate ligament surgery

Free Radical Biology and Medicine

Volumn 46, Issue 5, 2009, Pages 599-606

  Barker, Tyler ^a,b,c   Leonard, Scott W ^c   Trawick, Roy H ^a,d   Martins, Thomas B ^e   Kjeldsberg, Carl R ^e,f   Hill, Harry R ^e,f   Traber, Maret G ^b,c  

^a Orthopedic Specialty Hospital   (United States)

^b OREGON STATE UNIVERSITY   (United States)

^c OREGON STATE UNIVERSITY   (United States)

^d The Orthopedic Specialty Clinic   (United States)

^e ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

^f UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Anterior cruciate ligament (ACL); Antioxidants; Cytokines

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; C REACTIVE PROTEIN; CREATINE KINASE; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; PLACEBO;

ADULT; ANTERIOR CRUCIATE LIGAMENT INJURY; ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HUMAN; INFLAMMATION; MALE; MODULATION; MUSCLE INJURY; POSTOPERATIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; VITAMIN SUPPLEMENTATION;

ADULT; ALPHA-TOCOPHEROL; ANTERIOR CRUCIATE LIGAMENT; ASCORBIC ACID; C-REACTIVE PROTEIN; CREATINE KINASE; CYTOKINES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; GAMMA-TOCOPHEROL; HUMANS; INFLAMMATION; MALE; MUSCULAR ATROPHY, SPINAL; RECONSTRUCTIVE SURGICAL PROCEDURES;

EID: 59249088843     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2008.11.006     Document Type: Article

References (69)

1. Arvidsson I., Arvidsson H., Eriksson E., and Jansson E. Prevention of quadriceps wasting after immobilization: an evaluation of the effect of electrical stimulation. Orthopedics 9 (1986) 1519-1528
2. Elmqvist L.G., Lorentzon R., Johansson C., Langstrom M., Fagerlund M., and Fugl-Meyer A.R. Knee extensor muscle function before and after reconstruction of anterior cruciate ligament tear. Scand. J. Rehab. Med. Suppl. 21 (1989) 131-139
3. Risberg M.A., Holm I., Steen H., Eriksson J., and Ekeland A. The effect of knee bracing after anterior cruciate ligament reconstruction: a prospective, randomized study with two years' follow-up. Am. J. Sports Med. 27 (1999) 76-83
4. Arangio G.A., Chen C., Kalady M., and Reed J.F. Thigh muscle size and strength after anterior cruciate ligament reconstruction and rehabilitation. JOSPT 26 (1997) 238-243
5. Rosenberg T.D., Franklin J.L., Baldwin G.N., and Nelson K.A. Extensor mechanism function after petallar tendon graft harvest for anterior cruciate ligament reconstruction. Am. J. Med. 20 (1992) 519-526
6. Willy C., Dahouk S., Starck C., Kaffenberger W., Gerngross H., and Plappert U.G. DNA damage in human leukocytes after ischemia/reperfusion injury. Free Radic. Biol. Med. 28 (2000) 1-12
7. Saricaoglu F., Dal D., Salman A.E., Atay O.A., Doral M.N., Salman M.A., Kilinc K., and Aypar U. Effect of low-dose N-acetyl-cysteine infusion on tourniquet-induced ischaemia-reperfusion injury in arthroscopic knee surgery. Acta Anaesthesiol. Scand. 49 (2005) 847-851
8. Zysk S.P., Fraunberger P., Veihelmann A., Dorger M., Kalteis T., Maier M., Pellengahr C., and Refior H.J. Tunnel enlargement and changes in synovial fluid cytokine profile following anterior cruciatae ligament reconstruction with petallar tendon and hamstring tendon autografts. Knee Surg. Sports Traumatol. Arthrosc. 12 (2004) 98-103
9. Hardin B.J., Campbell K.S., Smith J.D., Arbogast S., Smith J., Moylan J.S., and Reid M.B. TNF-{alpha} acts via TNFR1 and muscle-derived oxidants to depress myofibrillar force in murine skeletal muscle. J. Appl. Physiol. 104 (2008) 694-699
10. Adams V., Nehrhoff B., Spate U., Linke A., Schulze P.C., Baur A., Gielen S., Hambrecht R., and Schuler G. Induction of iNOS expression in skeletal muscle by IL-1beta and NFkappaB activation: an in vitro and in vivo study. Cardiovasc. Res. 54 (2002) 95-104
11. Dehoux M., Gobier C., Lause P., Bertrand L., Ketelslegers J.M., and Thissen J.P. IGF-I does not prevent myotube atrophy caused by proinflammatory cytokines despite activation of Akt/Foxo and GSK-3beta pathways and inhibition of atrogin-1 mRNA. Am. J. Physiol. Endocrinol. Metab. 292 (2007) E145-E150
12. Li Y.P., Schwartz R.J., Waddell I.D., Holloway B.R., and Reid M.B. Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-κB activation in response to tumor necrosis factor α. FASEB J. 12 (1998) 871-880
13. Goodman M.N. Tumor necrosis factor induces skeletal muscle protein breakdown in rats. Am. J. Physiol. Endocrinol. Metab. 260 (1991) E727-E730
14. Goodman M.N. Interleukin-6 induces skeletal muscle protein breakdown in rats. Proc. Soc. Exp. Biol. Med. 205 (1994) 182-185
15. Dinarello C.A. Proinflammatory cytokines. Chest 118 (2000) 503-508
16. Toth M.J., Ades P.A., Tischler M.D., Tracy R.P., and LeWinter M.M. Immune activation is associated with reduced skeletal muscle mass and physical function in chronic heart failure. Int. J. Cardiol. 109 (2006) 179-187
17. van Helvoort H.A., Heijdra Y.F., de Boer R.C., Swinkels A., Thijs H.M., and Dekhuijzen P.N. Six-minute walking-induced systemic inflammation and oxidative stress in muscle-wasted COPD patients. Chest 131 (2007) 439-445
18. Visser M., Pahor M., Taaffe D.R., Goodpaster B.H., Simonsick E.M., Newman A.B., Nevitt M., and Harris T.B. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J. Gerontol. A Biol. Sci. Med. Sci. 57 (2002) M326-M332
19. Shi S., and Klotz U. Clinical use and pharmacological properties of selective COX-2 inhibitors. Eur. J. Clin. Pharmacol. 64 (2008) 233-252
20. Traber M.G., and Atkinson J. Vitamin E, antioxidant and nothing more. Free Radic. Biol. Med. 43 (2007) 4-15
21. Frei B., England L., and Ames B.N. Ascorbate is an outstanding antioxidant in human blood plasma. Proc. Natl. Acad. Sci. USA 86 (1989) 6377-6381
22. Halliwell B., and Gutteridge J.M.C. Free radicals in biology and medicine (1999), Oxford University Press, New York
23. Devaraj S., Tang R., Adams-Huet B., Harris A., Seenivasan T., de Lemos J.A., and Jialal I. Effect of high-dose alpha-tocopherol supplementation on biomarkers of oxidative stress and inflammation and carotid atherosclerosis in patients with coronary artery disease. Am. J. Clin. Nutr. 86 (2007) 1392-1398
24. Devaraj S., Leonard S., Traber M.G., and Jialal I. Gamma-tocopherol supplementation alone and in combination with alpha-tocopherol alters biomarkers of oxidative stress and inflammation in subjects with metabolic syndrome. Free Radic. Biol. Med. 44 (2008) 1203-1208
25. Devaraj S., and Jialal I. Alpha tocopherol supplementation decreases serum C-reactive protein and monocyte interleukin-6 levels in normal volunteers and type 2 diabetic patients. Free Radic. Biol. Med. 29 (2000) 790-792
26. Appell H.J., Duarte J.A.R., and Soares J.M.C. Supplementation of vitamin E may attenuate skeletal muscle immobilization atrophy. Int. J. Sports Med. 18 (1997) 157-160
27. Servais S., Letexier D., Favier R., Duchamp C., and Desplanches D. Prevention of unloading-induced atrophy by vitamin E supplementation: links between oxidative stress and soleus muscle proteolysis?. Free Radic. Biol. Med. 42 (2007) 627-635
28. Bruno R.S., Leonard S.W., Atkinson J., Montine T.J., Ramakrishnan R., Bray T.M., and Traber M.G. Faster plasma vitamin E disappearance in smokers is normalized by vitamin C supplementation. Free Radic. Biol. Med. 40 (2006) 689-697
29. Halpner A.D., Handelman G.J., Harris J.M., Belmont C.A., and Blumberg J.B. Protection of vitamin C of loss of vitamin E in cultured rat hepatocytes. Arch. Biochem. Biophys. 359 (1998) 305-309
30. Levine M., Conry-Cantilena C., Wang Y., Welch R.W., Washko P.W., Dhariwal K.R., Park J.B., Lazarev A., Graumlich J.F., King J., and Cantilena L.R. Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc. Natl. Acad. Sci. USA 93 (1996) 3704-3709
31. Bergman M., Salman H., Djaldetti M., Fish L., Punsky I., and Bessler H. In vitro immune response of human peripheral blood cells to vitamins C and E. J. Nutr. Biochem. 15 (2004) 45-50
32. Podda M., Weber C., Traber M.G., and Packer L. Simultaneous determination of tissue tocopherols, tocotrienols, ubiquinols, and ubiquinones. Lipid Res. 37 (1996) 893-901
33. Mastaloudis A., Morrow J.D., Hopkins D.W., Devaraj S., and Traber M.G. Antioxidant supplementation prevents exercise-induced lipid peroxidation, but not inflammation, in ultramarathon runners. Free Radic. Biol. Med. 36 (2004) 1329-1341
34. Martins T.B., Anderson J.L., Muhlestein J.B., Horne B.D., Carlquist J.F., Roberts W.L., and Carlquist J.F. Risk factor analysis of plasma cytokines in patients with coronary artery disease by a multiplexed fluorescent immunoassay. Am. J. Clin. Pathol. 125 (2006) 906-913
35. Miyazawa K., Mori A., Miyata H., Akahane M., Ajisawa Y., and Okudaira H. Regulation of interleukin-1beta-induced interleukin-6 gene expression in human fibroblast-like synoviocytes by p38 mitogen-activated protein kinase. J. Biol. Chem. 273 (1998) 24832-24838
36. Georganas C., Liu H., Perlman H., Hoffmann A., Thimmapaya B., and Pope R.M. Regulation of IL-6 and IL-8 expression in rheumatoid arthritis synovial fibroblasts: the dominant role for NF-kappa B but not C/EBP beta or c-Jun. J. Immunol. 165 (2000) 7199-7206
37. Akira S., Taga T., and Kishimoto T. Interleukin-6 in biology and medicine. Adv. Immunol. 54 (1993) 1-78
38. Bartoccioni E., Michaelis D., and Hohlfeld R. Constitutive and cytokine-induced production of interleukin-6 by human myoblasts. Immunol. Lett. 42 (1994) 135-138
39. Castell J.V., Gomez-Lechon M.J., David M., Hirano T., Kishimoto T., and Heinrich P.C. Recombinant human interleukin-6 (IL-6/BSF-2/HSF) regulates the synthesis of acute phase proteins in human hepatocytes. FEBS Lett. 232 (1988) 347-350
40. Geiger T., Andus T., Klapproth J., Hirano T., Kishimoto T., and Heinrich P.C. Induction of rat acute-phase proteins by interleukin 6 in vivo. Eur. J. Immunol. 18 (1988) 717-721
41. 2 and tumor necrosis factor-alpha in endothelial and epithelial cells. J. Biol. Chem. 272 (1997) 32910-32918
42. DeForge L.E., Preston A.M., Takeuchi E., Kenney J., Boxer L.A., and Remick D.G. Regulation of interleukin 8 gene expression by oxidant stress. J. Biol. Chem. 268 (1993) 25568-25576
43. DeForge L.E., Fantone J.C., Kenney J.S., and Remick D.G. Oxygen radical scavengers selectively inhibit interleukin 8 production in human whole blood. J. Clin. Invest. 90 (1992) 2123-2129
44. Higuchi H., Shirakura K., Kimura M., Terauchi M., Shinozaki T., Watanabe H., and Takagishi K. Changes in biochemical parameters after anterior cruciate ligament injury. Int. Orthop. 30 (2006) 43-47
45. Cameron M., Buchgraber A., Passler H., Vogt M., Thonar E., Fu F., and Evans C.H. The natural history of the anterior cruciate ligament-deficient knee. Changes in synovial fluid cytokine and keratan sulfate concentrations. Am. J. Sports Med. 25 (1997) 751-754
46. Irie K., Uchiyama E., and Iwaso H. Intraarticular inflammatory cytokines in acute anterior cruciate ligament injured knee. Knee 10 (2003) 93-96
47. Kosmidou I., Vassilakopoulos T., Xagorari A., Zakynthino S., Papapetropoulos A., and Roussos C. Production of interleukin-6 by skeletal myotubes. Am. J. Respir. Cell Mol. Biol. 26 (2002) 587-593
48. Tsujinaka T., Fujita J., Ebisui C., Yano M., Kominami E., Suzuki K., Tanaka K., Katsume A., Ohsugi Y., Shiozaki H., and Monden M. Interleukin 6áreceptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6átransgenic mice. J. Clin. Invest. 97 (1996) 244-249
49. Haddad F., Zaldivar F., Cooper D.M., and Adams G.R. IL-6-induced muscle atrophy. J. Appl. Physiol. 98 (2005) 911-917
50. Powers S.K., kavazis A.N., and McClung J.M. Oxidative stress and disuse muscle atrophy. J. Appl. Physiol. 102 (2007) 2389-2397
51. Reid M.B. Free radicals and muscle fatigue: of ROS, canaries, and the IOC. Free Radic. Biol. Med. 44 (2008) 169-179
52. Suzuki N., Motohashi N., Uezumi A., Fukada S., Yoshimura T., Itoyama Y., Aoki M., Miyagoe-Suzuki Y., and Takeda S. NO production results in suspension-induced muscle atrophy through dislocation of neuronal NOS. J. Clin. Invest. 117 (2007) 2468-2476
53. McClung J.M., kavazis A.N., Whidden M.A., DeRuisseau K.C., Falk D.J., Criswell D.S., and Powers S.K. Antioxidant administration attenuates mechanical ventilation-induced rat diaphragm muscle atrophy independent of protein kinase B (PKB/Akt) signaling. J. Physiol. 585 (2007) 203-215
54. 2+ sensitivity in fatiguing mouse skeletal muscle at 37 degrees C. J. Physiol. (London) 564 (2005) 189-199
55. + sensitivity in mouse skeletal muscle is reversed by dithiothreitol. J. Physiol. (London) 571 (2006) 191-200
56. Wu J.H., Ward N.C., Indrawan A.P., Almeida C.A., Hodgson J.M., Proudfoot J.M., Puddey I.B., and Croft K.D. Effects of alpha-tocopherol and mixed tocopherol supplementation on markers of oxidative stress and inflammation in type 2 diabetes. Clin. Chem. 53 (2007) 511-519
57. Eskdale J., Kube D., and Gallagher G. A second polymorphic dinucleotide repeat in the 5′ flanking region of the human IL10 gene. Immunogenetics 45 (1996) 82-83
58. Kim J.M., Brannan C.I., Copeland N.G., Jenkins N.A., Khan T.A., and Moore K.W. Structure of the mouse IL-10 gene and chromosomal localization of the mouse and human genes. J. Immunol. 148 (1992) 3618-3623
59. Moore K.W., Vieira P., Fiorentino D.F., Trounstine M.L., Khan T.A., and Mosmann T.R. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science 248 (1990) 1230-1234
60. Deblier I., Sadowska A.M., Janssens A., Rodrigus I., and DeBacker W.A. Markers of inflammation and oxidative stress in patients undergoing CABG with CPB with and without ventilation of the lungs: a pilot study. Interact. Cardiovasc. Thorac. Surg. 5 (2006) 387-391
61. Strieter R.M., Kunkel S.L., Showell H.J., Remick D.G., Phan S.H., Ward P.A., and Marks R.M. Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-alpha, LPS, and IL-1 beta. Science 243 (1989) 1467-1469
62. Wang P., Wu P., Anthes J.C., Siegel M.I., Egan R.W., and Billah M.M. Interleukin-10 inhibits interleukin-8 production in human neutrophils. Blood 83 (1994) 2678-2683
63. Wang P., Wu P., Siegel M.I., Egan R.W., and Billah M.M. IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. J. Immunol. 153 (1994) 811-816
64. Massion P.P., Linden A., Inoue H., Mathy M., Grattan K.M., and Nadel J.A. Dimethyl sulfoxide decreases interleukin-8-mediated neutrophil recruitment in the airways. Am. J. Physiol. 271 (1996) L838-L843
65. Novelli G.P., Adembri C., Gandini E., Orlandini S.Z., Papucci L., Formigli L., Manneschi L.I., Quattrone A., Pratesi C., and Capaccioli S. Vitamin E protects human skeletal muscle from damage during surgical ischemia-reperfusion. Am. J. Surg. 172 (1996) 206-209
66. Formigli L., Manneschi L.I., Tani A., Gandini E., Adembri C., Pratesi C., Novelli G.P., and Orlandini S.Z. Vitamin E prevents neutrophil accumulation and attenuates tissue damage in ischemic-reperfused human skeletal muscle. Histol. Histopathol. 12 (1997) 663-669
67. Kearns S.R., Moneley D., Murray P., Kelly C., and Daly A.F. Oral vitamin C attenuates acute ischaemia-reperfusion injury in skeletal muscle. J. Bone Joint Surg. (Br.) 83 (2001) 1202-1206
68. Kearns S.R., Daly A.F., Sheehan K., Murray P., Kelly C., and Bouchier-Hayes D. Oral vitamin C reduces injury to skeletal muscle caused by compartment syndrome. J. Bone Jt. Surg. (Br.) 86-B (2004) 906-911
69. Judge A.R., Selsby J.T., and Dodd S.L. Antioxidants attenuate oxidative damage in rat skeletal muscle during mild ischaemia. Exp. Physiol. 93 (2008) 479-485